주메뉴
메인비쥬얼
Group Introduction
메인 컨텐츠
News
Total 69, 7/7 Page
| Number | Title | Date | Read |
|---|---|---|---|
| 9 | Huonslab Receives IND Approval from MFDS to Start Pivotal Clinica.. | 2024-08-07 | 2945 |
| 8 | Huons Meditech Showcases Key Products at FIME 2024 in Florida | 2024-06-25 | 3392 |
| 7 | Huons Meditech Targets South American Market at `Hospitalar 2024`.. | 2024-05-27 | 2622 |
| 6 | “Huonslab Completes IND Submission for Recombinant Human Hyalur.. | 2024-04-29 | 4526 |
| 5 | Huons Meditech wins `$7 million Export Tower awards` | 2023-12-07 | 2991 |
| 4 | Huonslab Confirms Recombinant Human Hyaluronidase Effectiveness | 2023-10-24 | 3507 |
| 3 | Huons Meditech Makes Strides with `Dermashine Pro` as TFDA Greenl.. | 2023-09-06 | 5645 |
| 2 | Huons, U.S. Patent Registered for `Quisqualis Extract` for Prosta.. | 2023-09-06 | 3323 |
| 1 | Huonslab Advances in Human Hyaluronidase Development | 2023-02-21 | 5792 |
푸터
Name: Huons Global|President: Sungtae Yoon, Sooyoung Song
Address: 9th Floor HuonsGlobal Bldg., A-dong Pangyo I-Square, 17, Changeop-ro, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea
TEL: 02)854-4700|FAX: 02)6455-0740|Customer Service: 080-447-4700|Corporate Registration Number: 129-81-07002
COPYRIGHT Huons Global ALL RIGHTS RESERVED. DESINGED BY SINBIWEB